Evaluation of the Efficacy of Respicure® (Resveratrol / Quercetin) in the Management of Respiratory Conditions Including Asthma,COPD and Long COVID.
Clinical trial NCT05601180 · COMPLETED
Trial details
- NCT number
- NCT05601180
- Sponsor
- Beker Laboratories
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-27
- Primary completion
- 2024-01-15
- Enrollment
- 402
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.